Vault-13

Ponoi Management, LLC

San Francisco, CA · CIK 1720702 · 13F filing filed 2022-05-16

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$77.0m reported value -29.0% vs Q4 2021
4positions
100.0%in top 10
0 new 0 added 0 reduced 0 sold out vs Q4 2021

Holdings, Q1 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 RAPT THERAPEUTICS INC COM COM 1,599,417 $35.2m45.65% 45.65% UnchangedShares held: Q2 2021 1.6m, Q3 2021 1.6m, Q4 2021 1.6m, Q1 2022 1.6m
2 NGM BIOPHARMACEUTICALS INC COM NGM NGM 1,298,908 $19.8m25.71% 25.71% UnchangedShares held: Q2 2021 1.3m, Q3 2021 1.3m, Q4 2021 1.3m, Q1 2022 1.3m
3 REVOLUTION MEDICINES INC COM RVMD RVMD 685,011 $17.5m22.68% 22.68% UnchangedShares held: Q2 2021 685.0k, Q3 2021 685.0k, Q4 2021 685.0k, Q1 2022 685.0k
4 NURIX THERAPEUTICS INC COM NRIX NRIX 327,122 $4.6m5.95% 5.95% UnchangedShares held: Q2 2021 686.3k, Q3 2021 561.6k, Q4 2021 327.1k, Q1 2022 327.1k